Dr. Lichter received her undergraduate and MD degrees in Winnipeg, Manitoba, and completed her ophthalmology training at the University of Toronto. She followed a pathology fellowship under the guidance of Dr. Lorenz Zimmerman and Dr. Ian MacLean in Washington DC, and returned to Toronto to do comprehensive medical ophthalmology.
Dr. Lichter was asked to run the HIV clinic at Saint Michael’s Hospital in 2000, when Saint Michael’s Hospital merged with Wellesley Hospital. She met a homeless blind person there, and though challenged, felt a need to do more for that segment of the population. Since then, she has been involved with homeless adults, youth, families, and refugees. Dr. Lichter continues to work and thrive in her medical practice, and enjoys teaching students and residents.
Financial disclosure: I do not have an affiliation (financial or otherwise) with a commercial organization.
Sessions in which Dr. Myrna Lichter participates
Friday 20 June, 2025
Learning ObjectivesAt the end of this session, participants will be able to:Assess the issues linked to eye care delivery in both Canada and globally.Understand the challenges and barriers to implement eye care services delivery in remote areas and underserved communities.
Learning ObjectivesAt the end of this session, participants will be able to:Assess the sources of emissions linked to eye care delivery in both clinical and surgical settings.Understand the challenges, barriers and opportunities to implement environmentally-sound eye care practices.
Saturday 21 June, 2025
Learning ObjectivesAt the end of this session, participants will be able to:Understand the Universal Eye Health Comprehensive Framework.Assess the Canadian National Strategy for Eye Care Act (Bill C-284)Compare ...
Learning ObjectivesAt the end of this session, participants will be able to:Understand the Universal Eye Health Comprehensive Framework.Assess translational strategies for implementing equitable, accessible, and high-quality eye care services.Compare various integrated models of eye care across the world....
Sunday 22 June, 2025
Sessions in which Dr. Myrna Lichter attends
Thursday 19 June, 2025
Additional authors: Davin Johnson, Thomas Herzinger, James Farmer, Ami Wang
Friday 20 June, 2025
Join us at this Accredited Symposium co-developed with COS and Amgen!Chaired by Vivian Yin and Navdeep Nijhawan.This co-developed symposium features four...
Learning ObjectivesAt the end of this session, participants will be able to:To challenge traditional attitudes and educate delegates regarding the ophthalmic simulation options available to ensure a safer surgical experience for the trainer, trainee and the patient (most importantly).
Learning ObjectivesAt the end of this session, participants will be able to:To understand how different patient populations experience vision impairment and eye disease due to structural and identity-based factors.
Saturday 21 June, 2025
Learning Objectives At the end of this session, participants will be able to:To improve surgical techniques during eye surgery in the digital age.To know the most common types of retinal pathologies that can result from myopia.Identify and articulate the current disparities in eye health outcomes across different populations, recognizing ...
Learning ObjectivesAt the end of this session, participants will be able to:Describe how suppressing and avoiding emotions contributes to stress and illnessDemonstrate the “design success” of painful emoti...
Sunday 22 June, 2025
Learning Objectives At the end of this session, participants will be able to:Be able to discuss at least 4 specific SDGs where high-quality evidence points to a causative association between vision interventions and improved outcomes.Describe recruitment challenges and strategies for enrolling underserved populations in clinical trials.<...
Learning ObjectivesAt the end of this session, participants will be able to:Discuss the history of Glaucoma and the evolution of the management strategies.Discuss risk stratification and controversial issues in primary, secondar...
To treat - Matt Schlenker / Not to treat - Steve Schendel
Systemic effects and or observation - Marjorie Carbonneau / IOP modifications - Amaka Eneh
Maximal Medical Therapy Option - Georges Durr / Surgery Option - Xavier Campos - Moller
My preference – Needling and or Medication: Delan Jiyapriya / My Preference - Tube Surgery: Gavin Docherty
Learning ObjectivesAt the end of this session, participants will be able to:Apply uveitis guidelines to the diagnosis and management of scleritis and retinal vasculitis. Assess the impact of age on ...